Expertise in
1
conditions

Oliver Klein

Neuss, NW, DE 
Expertise in
1
conditions
Neuss, NW, DE 

Overview

Oliver Klein practices practicing medicine in Neuss, Germany.

Mr. Klein is highly rated in 1 condition, according to our data. His clinical expertise encompasses Type 1 Diabetes (T1D), Type 2 Diabetes (T2D), Diabetic Ketoacidosis, and Maturity Onset Diabetes of the Young.

He is actively involved in clinical research, co-authoring 13 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

Neuss, NW, Germany
Other Locations
Mainz, RP, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Study to Assess the Pharmacokinetics, Glucodynamics, Safety, and Tolerability of LY900027 in Patients With Type 1 Diabetes Mellitus on Continuous Subcutaneous Insulin Infusion Therapy
A Study to Assess the Pharmacokinetics, Glucodynamics, Safety, and Tolerability of LY900027 in Patients With Type 1 Diabetes Mellitus on Continuous Subcutaneous Insulin Infusion Therapy
Enrollment Status: Completed
Publish Date: August 05, 2020
Intervention Type: Drug
Study Phase: Phase 1
G-Pen (Glucagon Injection) Compared to GlucaGen® Hypokit® (Glucagon) for Induced Hypoglycemia Rescue in Adults With T1D: A Phase 3 Multi-center, Randomized, Controlled, Single Blind, 2-way Crossover Study to Evaluate Efficacy and Safety
G-Pen (Glucagon Injection) Compared to GlucaGen® Hypokit® (Glucagon) for Induced Hypoglycemia Rescue in Adults With T1D: A Phase 3 Multi-center, Randomized, Controlled, Single Blind, 2-way Crossover Study to Evaluate Efficacy and Safety
Enrollment Status: Completed
Publish Date: May 22, 2020
Intervention Type: Drug
Study Phase: Phase 3
View 1 Less Clinical Trial

13 Total Publications

Characterisation of steady-state pharmacokinetics and glucodynamics of once-weekly insulin efsitora alfa in individuals with type 2 diabetes.
Characterisation of steady-state pharmacokinetics and glucodynamics of once-weekly insulin efsitora alfa in individuals with type 2 diabetes.
Journal: Diabetes, obesity & metabolism
Published: December 02, 2025

Frequently Asked Questions about Oliver Klein

Is Oliver Klein a top-rated expert for Type 1 Diabetes (T1D)?

MediFind is an objective health platform that identifies experts based on real-world data. Oliver Klein is classified as an Advanced expert for Type 1 Diabetes (T1D), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Oliver Klein participate in research or clinical trials?

Yes. Oliver Klein has published 13 articles and abstracts on conditions like Type 1 Diabetes (T1D). You can view a list of Oliver Klein's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Klein's expertise for a condition
ConditionClose
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile